CD8A and oropharynx cancer: Data presented here demonstrate that the adaptive immunity from total and HPV-antigen-specific CD8 T cells as well as the innate immunity from NK cell subsets both contribute towards the therapeutic vaccine-mediated protection against HPV oral tumors in the established preclinical model for HPV+ oropharyngeal cancers.